VICP — Vicapsys Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $57.30m
- $57.79m
- 15
- 58
- 58
- 40
Annual cashflow statement for Vicapsys Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.03 | -0.766 | -0.237 | -0.985 | -1.18 |
| Amortisation | |||||
| Non-Cash Items | -0.014 | 0.015 | -0.096 | 0.446 | 0.136 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.047 | 0.457 | -0.143 | 0.269 | 0.629 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.97 | -0.263 | -0.444 | -0.238 | -0.418 |
| Other Investing Cash Flow Items | — | — | 0.1 | 0 | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | — | — | 0.1 | 0 | — |
| Financing Cash Flow Items | 0.177 | 0 | — | -0.015 | 0.05 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.15 | 0 | 0.56 | 0.035 | 0.413 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.178 | -0.263 | 0.216 | -0.203 | -0.005 |